Boston’s chief federal prosecutor is scrutinizing his lawyers’ biopharma investigations amid perceptions the office has lost its reputation as the Justice Department’s most feared health-care fraud enforcer.
Joshua Levy, now the acting head and White House nominee to lead the US attorney’s office in Massachusetts, is relying on his decades of experience as the health-care industry’s go-to defense attorney opposite DOJ as he examines legal theories and evidence his line prosecutors pursue in the medical field.
“I am very much interested in the health-care fraud cases because I feel like I know the space; I hope I can add value,” ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.